Top Markets
Coin of the day
Aceragen, Inc. Aceragen, Inc.

Aceragen, Inc.

ACGN
Classificação em ações #39037
Aceragen, Inc., a biopharmaceutical firm in its clinical development phase,... Aceragen, Inc., a biopharmaceutical firm in its clinical development phase, operates out of Exton, Pennsylvania, and was founded in 1989. The company, which transitioned from Idera Pharmaceuticals, Inc. and adopted its current name in January 2023, concentrates on the discovery, advancement, and bringing to market of therapeutic agents for uncommon lung and autoimmune conditions exclusively within the United States. Its product development pipeline includes ACG-701, currently undergoing Phase 2 clinical evaluation for both cystic fibrosis pulmonary exacerbations and melioidosis, as well as ACG-801, which is being developed to address Farber disease. Moreover, Aceragen maintains a partnership and option agreement with Scriptr Global, Inc. This collaboration aims to pinpoint, research, and cultivate gene therapy options intended for the management, palliation, diagnosis, or prevention of myotonic dystrophy type 1 and Friedreich's Ataxia.
Preço da ação
$0.38
Última sincronização: 2023-09-01
Valor de mercado
$677.16K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Aceragen, Inc. (ACGN)

Categoria

Histórico de preços das ações de Aceragen, Inc. (ACGN)
Preço de fecho mais alto: $0.38 em 2023-09-01

Preço de fecho mais baixo: $64.33K em 1996-01-01
Histórico de preços das ações da Aceragen, Inc. de 1996 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2023 -92.15%
2022 -56.36%
2021 -85.30%
2020 156.42%
2019 -62.29%
2018 -71.51%
2017 25.28%
2016 -54.63%
2015 -10.86%
2014 28.19%
2013 290.03%
2012 -27.35%
2011 -57.65%
2010 -48.14%
2009 -35.84%
2008 -34.66%
2007 126.13%
2006 11.76%
2005 25.16%
2004 -60.39%
2003 51.06%
2002 -54.68%
2001 218.06%
2000 -48.13%
1999 -40.76%
1998 -61.27%
1997 -85.90%
1996 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$517.18 32.51%
US
$857.76 31.47%
NL
$728.05 6.60%
CH
$1.07K -6.40%
KR
$254.79 12.56%
BE